RAP1GAP inhibits cytoskeletal remodeling and motility in thyroid cancer cells

Endocrine-Related Cancer

Volumn 19, Issue 4, 2012, Pages 575-588

  Dong, Xiaoyun ^a   Tang, Waixing ^a   Stopenski, Stephen ^a   Brose, Marcia S ^a   Korch, Christopher ^b   Meinkoth, Judy L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FOCAL ADHESION KINASE; PAXILLIN; PROTEIN; PROTEIN DERIVATIVE; RAP1 PROTEIN; RAP1GAP PROTEIN; RAP2 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CARCINOMA CELL; CELL MIGRATION; CELL MOTILITY; CELL SPREADING; CYTOARCHITECTURE; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; THYROID CANCER; THYROID CELL; THYROID FOLLICLE CELL; THYROID GLAND; THYROID PAPILLARY CARCINOMA; THYROID TUMOR;

CARCINOMA, PAPILLARY; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETON; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GTPASE-ACTIVATING PROTEINS; HT29 CELLS; HUMANS; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RAP GTP-BINDING PROTEINS; RAP1 GTP-BINDING PROTEINS; THYROID NEOPLASMS; TRANSFECTION;

EID: 84864398785     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-12-0086     Document Type: Article

References (38)

1. Avizienyte E & Frame MC 2005 Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Current Opinion in Cell Biology 17 542-547. (doi:10.1016/j.ceb.2005.08.007)
2. Banerjee R, Mani RS, Russo N, Scanlon CS, Tsodikov A, Jing X, Cao Q, Palanisamy N, Metwally T, Inglehart RC et al. 2011 The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma. Oncogene 30 4339-4349. (doi:10.1038/onc.2011.141)
3. Bivona TG, Wiener HH, Ahearn IM, Silletti J, Chiu VK & Philips MR 2004 Rap1 up-regulation and activation on plasma membrane regulates T cell adhesion. Journal of Cell Biology 164 461-470. (doi:10.1083/jcb.200311093)
4. Bos JL 2005 Linking Rap to cell adhesion. Current Opinion in Cell Biology 17 123-128. (doi:10.1016/j.ceb.2005.02.009)
5. Caccia D, Micciche F, Cassinelli G, Mondellini P, Casalini P & Bongarzone I 2010 Dasatinib reduces FAK phosphorylation increasing the effects of RPI-1 inhibition in a RET/PTC1-expressing cell line. Molecular Cancer 9 278. (doi:10.1186/1476-4598-9-278)
6. Carlomagno F & Santoro M 2011 Thyroid cancer in 2010: a roadmap for targeted therapies. Nature Reviews. Endocrinology 7 65-67. (doi:10.1038/nrendo. 2010.232)
7. Chevillard S, Ugolin N, Vielh P, Ory K, Levalois C, Elliott D, Clayman GL & El-Naggar AK 2004 Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. Clinical Cancer Research: an Official Journal of the American Association for Cancer Research 10 6586-6597. (doi:10.1158/1078-0432.CCR-04-0053)
8. Christian SL, Lee RL, McLeod SJ, Burgess AE, Li AH, Dang-Lawson M, Lin KB & Gold MR 2003 Activation of the Rap GTPases in B lymphocytes modulates B cell antigen receptor-induced activation of Akt but has no effect on MAPK activation. Journal of Biological Chemistry 278 41756-41767. (doi:10.1074/jbc.M303180200)
9. Connelly SF, Isley BA, Baker CH, Gallick GE & Summy JM 2010 Loss of tyrosine phosphatase-dependent inhibition promotes activation of tyrosine kinase c-Src in detached pancreatic cells. Molecular Carcinogenesis 49 1007-1021. (doi:10.1002/mc.20684)
10. Dahlman T, Lammerts E, Wik M, Bergstrom D, Grimelius L, Westermark K, Rubin K & Heldin NE 2000 Fibrosis in undifferentiated (anaplastic) thyroid carcinomas: evidence for a dual action of tumour cells in collagen type I synthesis. Journal of Pathology 191 376-386. (doi:10.1002/1096-9896(2000)9999: 9999〈::AIDPATH643〉3.0.CO;2-W)
11. Dong X, Korch C & Meinkoth JL 2011 Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells. Endocrine-Related Cancer 18 301-310. (doi:10.1530/ERC-10-0320)
12. Freeman SA, McLeod SJ, Dukowski J, Austin P, Lee CC, Millen-Martin B, Kubes P, McCafferty DM, Gold MR & Roskelley CD 2010 Preventing the activation or cycling of the Rap1 GTPase alters adhesion and cytoskeletal dynamics and blocks metastatic melanoma cell extravasation into the lungs. Cancer Research 70 4590-4601. (doi:10.1158/0008-5472.CAN-09-3414)
13. Gloerich M & Bos JL 2011 Regulating Rap small G-proteins in time and space. Trends in Cell Biology 21 615-623. (doi:10.1016/j.tcb.2011.07.001)
14. Janoueix-Lerosey I, Fontenay M, Tobelem G, Tavitian A, Polakis P & de Gunzburg J 1994 Phosphorylation of Rap1GAP during the cell cycle. Biochemical and Biophysical Research Communications 202 967-975. (doi:10.1006/bbrc.1994. 2024)
15. Knauf JA & Fagin JA 2009 Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets. Current Opinion in Cell Biology 21 296-303. (doi:10.1016/j.ceb.2009.01.013)
16. Lin KB, Tan P, Freeman SA, Lam M, McNagny KM & Gold MR 2010 The Rap GTPases regulate the migration, invasiveness and in vivo dissemination of B-cell lymphomas. Oncogene 29 608-615. (doi:10.1038/onc.2009.345)
17. Loza-Coll MA, Perera S, Shi W & Filmus J 2005 A transient increase in the activity of Src-family kinases induced by cell detachment delays anoikis of intestinal epithelial cells. Oncogene 24 1727-1737. (doi:10.1038/sj.onc. 1208379)
18. Lu C, Zhao L, Ying H, Willingham MC & Cheng SY 2010 Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma. Endocrinology 151 1929-1939. (doi:10.1210/en.2009- 1017)
19. Mitra RS, Goto M, Lee JS, Maldonado D, Taylor JM, Pan Q, Carey TE, Bradford CR, Prince ME, Cordell KG et al. 2008 Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma. Cancer Research 68 3959-3969. (doi:10.1158/0008-5472.CAN-07-2755)
20. Nellore A, Paziana K, Ma C, Tsygankova OM, Wang Y, Puttaswamy K, Iqbal AU, Franks SR, Lv Y, Troxel AB et al. 2009 Loss of Rap1GAP in papillary thyroid cancer. Journal of Clinical Endocrinology and Metabolism 94 1026-1032. (doi:10.1210/jc.2008-1042)
21. Ohba Y, Mochizuki N, Matsuo K, Yamashita S, Nakaya M, Hashimoto Y, Hamaguchi M, Kurata T, Nagashima K & Matsuda M 2000 Rap2 as a slowly responding molecular switch in the Rap1 signaling cascade. Molecular and Cellular Biology 20 6074-6083. (doi:10.1128/MCB.20.16.6074-6083.2000)
22. Prabakaran I, Grau JR, Lewis R, Fraker DL & Guvakova MA 2011 Rap2A is upregulated in invasive cells dissected from follicular thyroid cancer. Journal of Thyroid Research 2011 1-6. (doi:10.4061/2011/979840)
23. Price LS, Hajdo-Milasinovic A, Zhao J, Zwartkruis FJ, Collard JG & Bos JL 2004 Rap1 regulates E-cadherin-mediated cell-cell adhesion. Journal of Biological Chemistry 279 35127-35132. (doi:10.1074/jbc.M404917200)
24. Raaijmakers JH & Bos JL 2009 Specificity in Ras and Rap signaling. Journal of Biological Chemistry 284 10995-10999. (doi:10.1074/jbc.R800061200)
25. Saji M & Ringel MD 2010 The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors. Molecular and Cellular Endocrinology 321 20-28. (doi:10.1016/j.mce.2009.10.016)
26. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow L, Copland JA, Smallridge RC et al. 2008 DNA profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. Journal of Clinical Endocrinology and Metabolism 93 4331-4341. (doi:10.1210/jc.2008-1102)
27. Schweppe RE, Kerege AA, French JD, Sharma V, Grzywa RL & Haugen BR 2009 Inhibition of Src with AZD0530 reveals the Src-focal adhesion kinase complex as a novel therapeutic target in papillary and anaplastic thyroid cancer. Journal of Clinical Endocrinology and Metabolism 94 2199-2203. (doi:10.1210/jc.2008-2511)
28. Spilker C & Kreutz MR 2010 RapGAPs in brain: multipurpose players in neuronal Rap signalling. European Journal of Neuroscience 32 1-9. (doi:10.1111/j.1460-9568.2010.07273.x)
29. van Staveren WC, Beeckman S, Tomas G, Dom G, Hebrant A, Delys L, Vliem MJ, Tresallet C, Andry G, Franc B et al. 2012 Role of Epac and protein kinase A in thyrotropin-induced gene expression in primary thyrocytes. Experimental Cell Research 318 444-452. (doi:10.1016/j.yexcr.2011.12.022)
30. Tsygankova OM, Feshchenko E, Klein PS & Meinkoth JL 2004 Thyroid-stimulating hormone/cAMP and glycogen synthase kinase 3{β} elicit opposing effects on Rap1GAP stability. Journal of Biological Chemistry 279 5501-5507. (doi:10.1074/jbc.M305824200)
31. Tsygankova OM, Prendergast GV, Puttaswamy K, Wang Y, Feldman MD, Wang H, Brose MS & Meinkoth JL 2007 Downregulation of Rap1GAP contributes to Ras transformation. Molecular and Cellular Biology 27 6647-6658. (doi:10.1128/MCB.00155-07)
32. Tsygankova OM, Ma C, Tang W, Korch C, Feldman MD, Lv Y, Brose MS & Meinkoth JL 2010 Downregulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion. Molecular and Cellular Biology 30 3262-3274. (doi:10.1128/MCB.01345-09)
33. Viglietto G, Amodio N, Malanga D, Scrima M & De Marco C 2011 Contribution of PKB/AKT signaling to thyroid cancer. Frontiers in Bioscience: a Journal and Virtual Library 16 1461-1487. (doi:10.2741/3799)
34. Vuchak LA, Tsygankova OM, Prendergast GV&Meinkoth JL 2009 Protein kinase A and B-Raf mediate extracellular signal-regulated kinase activation by thyrotropin. Molecular Pharmacology 76 1123-1129. (doi:10.1124/mol.109.060129)
35. Zhang L, Chenwei L, Mahmood R, van Golen K, Greenson J, Li G, D'Silva NJ, Li X, Burant CF, Logsdon CD et al. 2006a Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer. Cancer Research 66 898-906. (doi:10.1158/0008-5472.CAN-05-3025)
36. Zhang Z, Mitra RS, Henson BS, Datta NS, McCauley LK, Kumar P, Lee JS, Carey TE & D'Silva NJ 2006b Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma. American Journal of Pathology 168 585-596. (doi:10.2353/ajpath.2006.050132)
37. Zheng H, Gao L, Feng Y, Yuan L, Zhao H & Cornelius LA 2009 Down-regulation of Rap1GAP via promoter hypermethylation promotes melanoma cell proliferation, survival, and migration. Cancer Research 69 449-457. (doi:10.1158/0008-5472.CAN-08-2399)
38. Zuo H, Gandhi M, Edreira MM, Hochbaum D, Nimgaonkar VL, Zhang P, Dipaola J, Evdokimova V, Altschuler DL & Nikiforov YE 2010 Downregulation of Rap1GAP through epigenetic silencing and loss of heterozygosity promotes invasion and progression of thyroid tumors. Cancer Research 70 1389-1397. (doi:10.1158/0008-5472.CAN-09-2812)